International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 1 : 925-928
Case Series
Pleomorphic Adenoma of the Minor Salivary Glands of the Hard Palate: A Case Series
 ,
 ,
Received
Dec. 23, 2025
Accepted
Jan. 15, 2026
Published
Jan. 29, 2026
Abstract

Introduction: Pleomorphic adenoma of the minor salivary glands of the hard palate is an uncommon benign neoplasm characterized by the presence of both epithelial and mesenchymal components. It typically presents as a slow-growing, painless submucosal mass of the hard palate. Diagnosis is based on clinical evaluation and histopathological examination, with radiological investigations aiding in assessment and surgical planning.

Aim and objective: This study adds a small series of cases to the existing literature on this relatively rare condition and discusses their clinical presentation and management.

Case description: We report a case series of three patients presenting with hard palate masses that were subsequently diagnosed as pleomorphic adenoma, with a discussion of their clinical management.

Conclusion: Treatment of choice for pleomorphic adenoma of hard palate is wide local excision with removal of periosteum with low recurrence rate.

Keywords
INTRODUCTION

Pleomorphic adenoma is the most common benign neoplasm of both major and minor salivary glands, with the hard palate being its predominant intraoral site (1). These tumors typically present as slow-growing, painless submucosal masses arising laterally due to the distribution of palatal minor salivary glands, their close proximity to periosteum may result in pressure effects or bone remodeling. Histologically, they consist of epithelial and myoepithelial components arranged in diverse patterns within a fibrous capsule of variable completeness (1,2). Despite being benign, pleomorphic adenoma warrants timely diagnosis and complete surgical excision due to its potential for continued growth and the rare possibility of malignant transformation(2,3,4). We report a case series detailing the clinical, radiological, and therapeutic aspects of pleomorphic adenoma of the hard palate treated at our institution.

 

Case description

Case 1.

A 59-year-old male presented to our outpatient department with an 8-month history of a gradually enlarging left palatal swelling (Image 1). The lesion was asymptomatic, with no associated pain, history of trauma, or relevant medical history. Intraoral examination revealed a well-circumscribed, 3 × 4 cm mass on the left anterior hard palate, covered by intact mucosa. The swelling was firm, non-tender, and non-mobile. There was no evidence of regional lymphadenopathy, and both general and systemic examinations were unremarkable. Fine-needle aspiration cytology (FNAC) indicated a pleomorphic adenoma. Computed tomography (CT) demonstrated a 2.9 × 3.5 × 1.2 cm lesion on the left hard palate, with no signs of periosteal erosion or bone invasion, consistent with a benign neoplastic process. The lesion was excised and diagnosis was confirmed to be pleomorphic adenoma. 6 months follow up showed no recurrence

 

 

Case 2.

A 50-year-old female came to our outpatient department complaining of a painless swelling over the palate for 1 year. On examination, a 2 × 1.5 × 1.5 cm3 non-tender, firm swelling was present on the right side of the hard palate with intact overlying mucosa (Image 2), with systemic and general examinations being normal. FNAC was done, which was suggestive of pleomorphic adenoma, while CECT scan showed it to be a benign neoplastic lesion over the right side of the hard palate with focal 4.5 mm breech in the floor of the nasal cavity and mild to moderate homogeneous post contrast enhancement. The lesion was excised, and histopathology confirmed a pleomorphic adenoma (Image 3 and 4). At the 6-month follow-up, no recurrence was observed.

 

Case 3.

A 40-year-old female patient came to us with a slow-growing swelling over the palate for the past 9 months. A 4 × 4 × 3 cm3 non-tender, soft to firm swelling was seen on the left side of the hard palate with normal overlying mucosa (Image 5). FNAC and CT scan showed it to be a pleomorphic adenoma without the involvement of the underlying bone. All these patients were treated by wide local excision without curettage of bone under general anesthesia (Image 6 and 7). The specimen was sent for histopathological examination, which confirmed the diagnosis of pleomorphic adenoma. The excised lesion was confirmed to be a pleomorphic adenoma, and no recurrence was detected at the 6-month review.

 

 

 

DISCUSSION

Pleomorphic adenoma arises from intercalated ductal and myoepithelial cells and is characterized by the presence of both epithelial and mesenchymal components. The epithelial elements may be arranged in duct-like structures, sheets, nests, or interlacing cords, while the stromal component can exhibit mucoid, myxoid, cartilaginous, or hyalinized features. These tumors are typically surrounded by a fibrous pseudocapsule rather than a true capsule (5,6).

 

Based on the relative proportions of epithelial and stromal elements, Seifert and colleagues classified pleomorphic adenoma into four histological types. Type I consists predominantly of a myxoid variant, Type II contains a mixture of myxoid and cellular components, Type III is mainly cellular, and Type IV represents an extremely cellular form. Pleomorphic adenomas arising from minor salivary glands tend to show a higher degree of cellularity compared to those of major salivary glands. Cytogenetic studies have demonstrated that pleomorphic adenoma is associated with clonal chromosomal abnormalities, most commonly involving regions 8q12 and 12q15 (7).

 

The differential diagnosis of pleomorphic adenoma includes both odontogenic and non-odontogenic cysts, palatal abscess, mucoepidermoid carcinoma, adenoid cystic carcinoma, rhabdomyosarcoma, lymphoma, and various soft tissue tumors such as neurofibroma, fibroma, lipoma, and schwannoma (2,8).

 

Diagnosis is established through a combination of patient history, clinical examination, cytological evaluation using fine-needle aspiration cytology (FNAC), and histopathological assessment. Imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) are valuable for determining the tumor’s size, location, and extent, as well as its involvement with adjacent superficial and deep structures. Core needle biopsy has been shown to provide a higher diagnostic accuracy, exceeding 97%, when compared to FNAC (8).

 

Management of pleomorphic adenoma of the hard palate involves wide local excision, including removal of the underlying periosteum or bone when involved (9). This approach is necessary because the tumor lacks a true capsule and often exhibits microscopic pseudopod-like extensions into surrounding tissues. Reconstruction is indicated when full-thickness bony defects are present and may be accomplished using a palatal flap based on the greater palatine vessels or an obturator prosthesis. Soft tissue defects without bony involvement may be allowed to heal by secondary intention. Reconstruction plays a critical role in preserving speech, swallowing, and facial contour (9,10).

 

According to Spiro, pleomorphic adenoma has an overall recurrence rate of approximately 6%. Recurrence is most often attributed to inadequate surgical techniques, including simple enucleation, capsular violation, or intraoperative tumor spillage. As a result, simple enucleation is strongly discouraged. Recurrent pleomorphic adenomas are frequently multinodular and lack a surrounding capsule, making subsequent surgical management more challenging. The risk of malignant transformation in pleomorphic adenoma is estimated to be around 6%(11).

 

CONCLUSION

Pleomorphic adenoma of the hard palate is an uncommon salivary gland tumor whose diagnosis relies on clinical evaluation, cytology, and histopathological confirmation. Wide local excision remains the treatment of choice, as it significantly reduces the risk of recurrence. Simple enucleation should be avoided due to its strong association with tumor recurrence.

 

REFERENCE

  1. Reddy GV, Siva Prasada Reddy G, Shahid MD et al. Pleomorphic Adenoma of the Palate: A Detailed Case Report and Surgical Outcome. Cureus; 2025.
  2. Seema R Gupta, Vandana P Thorawade, Mohammad Hanif, MS Khan.  Pleomorphic Adenoma of Hard Palate: A Case Series. Otorhinolaryngology Clinics: An International Journal, Volume 12 Issue 1 (January–April 2020).
  3. Sharma Y, Maria A, Chhabria A. Pleomorphic adenoma of the palate. Natl J Maxillofac Surg 2011;2:169-71.
  4. Suhail Amin Patigaroo, Fozia Amin Patigaroo, Junaid Ashraf , Nazia Mehfooz , Mohd Shakeel , Nazir A. Khan, Masood H. Kirmani. Pleomorphic Adenoma of Hard Palate: An Experience. J. Maxillofac. Oral Surg. (Jan–Mar 2014) 13(1):36–41.
  5. Singh OP, Mariyapragasam M, Marak ER, Hynniewta L. Pleomorphic adenoma of the hard palate: a case series. Int J Otorhinolaryngol Head Neck Surg. 2025;11(4):404–407.
  6. Zemmouri Y, Chbicheb S. Pleomorphic adenoma of hard palate: a case report. Pan Afr Med J. 2021;38:146.
  7. Seifert G, Miehlke A, Haubrich J, Chilla R. Diseases of the Salivary Glands. Stuttgart: Thieme; 1986.
  8. Patigaroo SA, Patigaroo FA, Ashraf J, et al. Pleomorphic adenoma of hard palate: an experience. J Maxillofac Oral Surg 2014 Mar;13(1):36– 41. DOI: 10.1007/s12663-012-0448-5.
  9. De Courten A, Lombardi T, Samson J. Pleomorphic adenoma in a child: 9-year follow-up. Int J Oral Maxillofac Surg 1996;25:293–295. DOI: 10.1016/S0901-5027(06)80060-3.
  10. Rahmana M, Orzedala-Koszel U, Czupkallo L, et al. Pleomorphic adenoma of the palate: a case report and review of the literature. Contemp Oncol (Pozn) 2013;17(1):103–106. DOI: 10.5114/ wo.2013.33438.
  11. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head & Neck Surgery. 1986;8(3):177–184.
Recommended Articles
Research Article Open Access
Study of prevalence of haemoglobin subtypes/variants in the ethnic population of Manipur
2026, Volume-7, Issue 1 : 2497-2500
Research Article Open Access
Comparative Analgesic Efficacy of Intrathecal Fentanyl versus Intrathecal Midazolam as Adjuvants to Hyperbaric Bupivacaine for Elective Caesarean Section: A Randomized Double-Blinded Clinical Trial
2026, Volume-7, Issue 1 : 2477-2484
Research Article Open Access
Prevalence of Rifampicin resistance detected by TrueNat assay in suspected pulmonary cases in a teritiary care hospital, Kurnool
2026, Volume-7, Issue 1 : 2492-2496
Research Article Open Access
Cancer Pattern at a Tertiary Care hospital in Pir Panjal (Rajouri & Poonch) region of Jammu and Kashmir
2026, Volume-7, Issue 1 : 2485-2491
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 1
Citations
49 Views
53 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved